VistaGen Therapeutics, Inc.VTGNNASDAQ
Loading
Year-over-year total asset growth rate
Percentile
P33
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -19.61% |
| Q3 2025 | 17.42% |
| Q2 2025 | -18.28% |
| Q1 2025 | -8.63% |
| Q4 2024 | -9.94% |
| Q3 2024 | -9.73% |
| Q2 2024 | -8.17% |
| Q1 2024 | -5.66% |
| Q4 2023 | 210.62% |
| Q3 2023 | 180.70% |
| Q2 2023 | -28.72% |
| Q1 2023 | -29.01% |
| Q4 2022 | -27.01% |
| Q3 2022 | -30.69% |
| Q2 2022 | -21.33% |
| Q1 2022 | -17.55% |
| Q4 2021 | -9.91% |
| Q3 2021 | -3.28% |
| Q2 2021 | -4.04% |
| Q1 2021 | -0.91% |
| Q4 2020 | 439.06% |
| Q3 2020 | 228.70% |
| Q2 2020 | 6.84% |
| Q1 2020 | 8.28% |
| Q4 2019 | -38.98% |
| Q3 2019 | -32.53% |
| Q2 2019 | -7.60% |
| Q1 2019 | 86.28% |
| Q4 2018 | -15.38% |
| Q3 2018 | 7.68% |
| Q2 2018 | -26.80% |
| Q1 2018 | -20.81% |
| Q4 2017 | 444.14% |
| Q3 2017 | 7.41% |
| Q2 2017 | -34.35% |
| Q1 2017 | -36.83% |
| Q4 2016 | -16.33% |
| Q3 2016 | -19.81% |
| Q2 2016 | 784.81% |
| Q1 2016 | -50.81% |